NeuroPace, Inc.
NPCE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,496 | -$8,651 | -$6,589 | -$5,250 |
| Dep. & Amort. | $487 | $477 | $462 | $451 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3,228 | $2,626 | $2,603 |
| Change in WC | -$1,671 | $2,093 | -$4,371 | -$3,003 |
| Other Non-Cash | $2,736 | $767 | $390 | $402 |
| Operating Cash Flow | -$1,944 | -$2,086 | -$7,482 | -$4,797 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$30 | -$168 | -$37 | -$39 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $2,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$30 | -$168 | -$37 | $1,961 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$133 | $0 | $0 | $0 |
| Stock Issued | -$49 | -$561 | $70,497 | $345 |
| Stock Repurch. | $0 | $0 | -$49,546 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$53 | -$1,347 | $157 | $503 |
| Financing Cash Flow | -$235 | -$1,908 | $21,108 | $848 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,209 | -$4,162 | $13,589 | -$1,988 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,857 | $27,141 | $13,552 | $15,540 |
| End Cash | $20,648 | $22,979 | $27,141 | $13,552 |
| Free Cash Flow | -$1,974 | -$2,254 | -$7,519 | -$4,836 |